openPR Logo
Press release

Cox 2 Inhibitors Market Competitive Insight and Key Drivers 2018-2026(Segmentation by Indication Osteoarthritis Rheumatoid Arthritis Menstrual Cramps Sports Injuries Others)

05-06-2019 09:00 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Cox 2 Inhibitors Market Competitive Insight and Key Drivers

Cox 2 Inhibitors are a type of non-steroidal anti-inflammatory drugs. These drugs are responsible for decreasing the production of prostaglandins.

These drugs also reduce the production of chemicals that play an important role in promoting fever, inflammatory pain etc. Cyclooxygenase (Cox) is an enzyme, which is responsible for producing prostaglandins. The cyclooxygenase enzymes are of two types- cox 1 and cox 2. Cox 2 inhibitors, reduce the production of prostaglandins, hence, can reduce inflammatory pain, fever etc.

There are some of the safety issues, associated with cox 2 inhibitors, hence, they have been taken off from the U.S. market.

Also, many products have been recalled in the market. For example- Vioxx, which is a cox 2 inhibitor, was recalled worldwide in 2004 as it caused cardiovascular diseases such as heart attacks and heart strokes. Bextra, which is another cox 2 inhibitor, was taken off from many European and U.S. markets in April 2005 due to cardiovascular risks and life-threatening skin reactions. There are many such other products like Prexige, which was withdrawn from most of the world’s market because of the severe liver damage caused by this drug. There are many controversies ongoing, which are criticizing the use of cox 2 inhibitors.

Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=3221

Celecoxib is the only COX-2 inhibitor, which is currently available in the United States. There is a new approach to manufacturing natural Cox 2 inhibitors, which is being adopted by the company, Sabinsa. Manufacture of natural Cox 2 inhibitors have very fewer side effects and is expected to be highly adopted by the people.

The high adoption rate of cox 2 inhibitors, such as aspirin pain killer, is one of the major factors, driving the growth of cox 2 inhibitors market. The increasing prevalence of chronic diseases, such as rheumatoid arthritis, osteoarthritis, and other diseases, is expected to increase the growth of cox 2 inhibitors market. Increasing awareness of physical activities can lead to sports injury, which can also be expected to drive the cox 2 inhibitors market.

The cox 2 inhibitors have many safety issues, hence, some of the cox 2 inhibitors have been withdrawn from the U.S. market. For example- Arcoxia is a cox 2 inhibitor, which is present in many countries but not in U.S. Dynastat is another cox 2 inhibitors, which is a form of injectable medicine and is not available in the U.S. market. The safety issues, associated with cox 2 inhibitors, can restrain the growth of cox 2 inhibitors market. Intake of cox 2 inhibitors, can also cause gastrointestinal problems for the people, which decreases the demand of ox 2 inhibitors, hence, can hamper the growth of the overall market. Other side effects, such as headache, migraine, nausea, also decreases the demand for cox 2 inhibitors.

The global Cox 2 Inhibitors market is segmented on the basis of product type, Indication, distribution channel, and geography:

Segmentation by Product type
Selective Cox 2 Inhibitors
Non Selective Cox 2 Inhibitors
Segmentation by Indication
Osteoarthritis
Rheumatoid Arthritis
Menstrual Cramps
Sports Injuries
Others
Segmentation by distribution channels
Hospital Pharmacies
Drug stores
Retail pharmacies
Based on the product type, the Cox 2 Inhibitors are segmented into selective cox 2 inhibitors and non- selective cox 2 inhibitors. Selective Cox 2 inhibitors are generally used for the treatment of osteoarthritis and rheumatoid arthritis. Selective Cox 2 inhibitors are expected to hold the largest revenue share in Cox 2 Inhibitors market. Non Selective Cox 2 inhibitors include drugs such as aspirin, ibuprofen etc. Basically, Cox 2 inhibitors are used to treat inflammatory pain. Based on the indication, the Cox 2 inhibitors market has been segmented into indication such as osteoarthritis, rheumatoid arthritis, menstrual cramps etc. Based on the end user, the market has been segmented into hospital pharmacies, drug stores, retail pharmacies. Drug stores are expected to show the maximum sales of Cox 2 inhibitors and can hold a large revenue share in the market.

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=3221

Geographically, global Cox 2 Inhibitors market has been divided into few regions, such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America is expected to dominate the cox 2 inhibitors global market due to the presence of high research and developmental activities. Europe is expected to hold the second largest share in the global Cox 2 Inhibitors market due to the presence of high population and high prevalence of rheumatoid arthritis. The Asia Pacific is expected to hold a large share in the cox 2 inhibitors market because of the presence of more number of people preferring inflammatory pan medicines.

There are only a few companies, such as Cadila Pharmaceuticals, which are manufacturing cox 2 inhibitors. Sabinsa manufactures natural herbal drugs and is focusing on manufacturing natural Cox 2 inhibitors.

The report covers exhaustive analysis on:

Cox 2 Inhibitors Market Segments
Cox 2 Inhibitors Market Dynamics
Historical Actual Market Size, 2013 - 2015
Cox 2 Inhibitors Market Size & Forecast 2016 to 2024
Cox 2 Inhibitors Agents Current Trends/Issues/Challenges
Competition & Companies involved
Cox 2 Inhibitors Market Drivers and Restraints
Regional analysis includes:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Report Highlights:

Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape
Strategies for key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

Report Analysis@ https://www.factmr.com/report/3221/cox-2-inhibitors-market

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cox 2 Inhibitors Market Competitive Insight and Key Drivers 2018-2026(Segmentation by Indication Osteoarthritis Rheumatoid Arthritis Menstrual Cramps Sports Injuries Others) here

News-ID: 1727826 • Views: 126

More Releases from Fact.MR

Introduction of Bio-based Coating Additives Likely to Navigate Future Sales, det …
Albany, New York, November 21, 2019: Fact.MR has recently updated a new study which comprehensively details about the expected trends and opportunities set to influence the global market for coating additives. Furthermore, the launch of green coatings is positively steering the coating additives market to enter a new phase. In the near future, the application of green coatings is likely to gain high-end popularity within the automotive industry, thereby, enhancing
11-20-2019 | Health & Medicine
Fact.MR
Dog and Cat Ownership are Primary Contributors to Growth of Animal Parasiticides …
Animal parasiticides are materials that are key ingredients in medicines that are used for veterinary purposes. These agents specialize in helping the health of animals and livestock, by killing parasites including microbial forms such as fungi and bacteria. The global market for animal parasiticides are expected to grow at a strong CAGR of over 6 per cent through the forecast period till 2026. This rapid rise is largely attributed to the
11-19-2019 | Health & Medicine
Fact.MR
Advances in Artificial Insemination to Play Substantial Role in Increasing Oppor …
Animal genetics is a branch in the field of genetics that are primarily involved with the study of gene variation for wild and domestic animals, which includes aspects such as animal breeding, gene expression, and physical genetic traits. Activities in the field involve genetic disease traiting, DNA testing, and genetic trait testing among others. The global animal genetics market is projected to grow at a strong CAGR of over 6 per
Ready Meal Trays’ Myriad Applications and Recyclability Spearheading the Food …
The ready meal trays market continues to showcase stunning prospects, with overall incremental opportunity of over US$ 1.7 Billion by 2027 from 2019, according to a recent Fact.MR study. Growth in consumption of packaged food products across both developed as well as developing countries is anticipated to increase the demand for ready meal trays during the forecast period. Ready meal trays are increasingly used by food processors and fast service

All 5 Releases


More Releases for Cox

Global Cox-2 Inhibitors Industry 2019-2025: Market Value, Trends and Demands Res …
The Global Cox-2 Inhibitors Industry Report 2019 is a professional and in-depth study on the current state of the Cox-2 Inhibitors Market. Key #Companies Analysis- Bayer, Novartis, Pfizer, Merck, Cadila Pharmaceuticals, Sabinsa Corporation Download Sample Research @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2091691 The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Cox-2 Inhibitors market analysis is provided for the international markets including development trends, competitive landscape analysis,
Cox-2 Inhibitors Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Cox-2 Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 102 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-cox-2-inhibitors-market_p108144.html   Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory
Cox 2 Inhibitors Market In-Depth Market Research Report 2018-2026(Segmentation b …
Cox 2 Inhibitors are a type of non-steroidal anti-inflammatory drugs. These drugs are responsible for decreasing the production of prostaglandins. These drugs also reduce the production of chemicals that play an important role in promoting fever, inflammatory pain etc. Cyclooxygenase (Cox) is an enzyme, which is responsible for producing prostaglandins. The cyclooxygenase enzymes are of two types- cox 1 and cox 2. Cox 2 inhibitors, reduce the production of prostaglandins, hence,
Travel Services Market Is Booming Worldwide | Cox & Kings, MakeMyTrip, Yatra
HTF MI recently introduced India 2017-2021 Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Cox & Kings, MakeMyTrip, SOTC, Thomas Cook, Yatra, Airbnb, Busindia.com, Cleartrip, Expedia,
Electronic Cleaning Market: ITW, Electrolube, ZESTRON, 3M, Cox Industries
HTF MI published a new industry research that focuses on Electronic Cleaning market and delivers in-depth market analysis and future prospects of Global Electronic Cleaning market. The study covers significant data which makes the research document a handy resource for managers, analysts, industry experts and other key people get ready-to-access and self-analyzed study along with graphs and tables to help understand market trends, drivers and market challenges. The study is
Global VoIP Market Prime Services, Production & Applications 2022 : AT & T, Vona …
Qyresearchreports include new market research report "Global VoIP Market Size, Status and Forecast 2022" to its huge collection of research reports. The report on the global market for VoIP attempts to help stakeholders in deriving a thorough understanding of the current trends and vulnerabilities of the market. It is comprised of relevant information that provide an in-depth picture of the global market for VoIP. This includes growth drivers and restraints molding